Llwytho...
Chemoresponse Assay in Head and Neck Cancer Patients: A Three-Year Follow Up
INTRODUCTION: The majority of patients with advanced head and neck cancer receiving chemotherapy show partial response or frank resistance. Therefore, assessing the individuals’ tumour reactivity to the eligible chemotherapeutic compounds carries the potential of personalizing the patient treatment...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Diagn Res |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
JCDR Research and Publications (P) Limited
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483792/ https://ncbi.nlm.nih.gov/pubmed/28658890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/24802.9816 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|